-
2022-501343-33-00
5
2023-10-18
Biochemically recurrent prostate cancer
-
2022-502322-41-00
5
2023-09-12
Metastatic breast cancer
-
2022-501176-26-00
5
2023-08-04
Acute Ischemic Stroke and High-Risk Transient Ischemic Attack
-
2022-501024-20-00
5
2023-07-25
ER+/HER2- Early Breast Cancer
-
2023-508499-12-00
5
2023-05-17
Systemic Lupus Erythematosus
-
2022-501608-85-00
5
2023-05-09
Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
-
2022-501939-16-00
5
2023-05-09
Heart failure (HF) with mildly reduced ejection fraction (HFmrEF) or H
-
2024-512890-28-00
5
2023-03-20
Primary immune thrombocytopenia (ITP)
-
2023-503928-10-00
4
2023-02-01
Prodromal and Early Manifest Huntington’s Disease
-
2023-504832-16-00
4
2023-01-24
DIFFUSE LARGE B CELL LYMPHOMA
-
2024-510947-71-00
5
2022-11-21
Chronic Myeloid Leukemia
-
2023-509859-13-00
5
2022-11-09
Relapsed or Refractory Multiple Myeloma (RRMM)
-
2023-508265-33-00
5
2022-10-13
Vasomotor symptoms caused by adjuvant endocrine therapy in women with,
-
2023-509750-58-00
5
2022-09-21
Polycythemia Vera
-
2023-508559-37-00
5
2022-07-14
Lupus nephritis
-
2024-511209-49-00
6
2022-04-26
Patients with hormone receptor positive HER2 negative locally advanced
-
2023-504597-37-00
5
2022-03-25
Focal segmental glomerulosclerosis
-
2024-511407-42-00
4
2022-01-10
Advanced Systemic Mastocytosis
-
2022-501067-40-00
5
2021-11-30
Moderately to Severely Active Ulcerative Colitis
-
2023-509843-28-00
5
2021-11-10
Paroxysmal Nocturnal Hemoglobinuria (PNH)
-
2023-508838-33-00
5
2021-10-06
Chronic Myeloid Leukemia
-
2023-506926-35-00
5
2021-09-24
Atherosclerotic cardiovascular disease, chronic kidney disease and sys
-
2023-508690-92-00
11
2021-09-20
IgA Nephropathy
-
2024-514473-21-00
5
2021-06-21
Primary diffuse large B-cell lymphoma (DLBCL) of the central nervous s